APA (7th ed.) Citation

BE, J., CS, K., JE, L., SJ, L., Y, C., HJ, S., . . . Y, J. (2026). Visomitin as a differentiation-inducing therapeutic agent through SYK inhibition in AML. Frontiers in pharmacology, 17, 1741351. https://doi.org/10.3389/fphar.2026.1741351

Chicago Style (17th ed.) Citation

BE, Jeon, Kwon CS, Lee JE, Lee SJ, Cho Y, Shin HJ, Kim SW, and Jung Y. "Visomitin as a Differentiation-inducing Therapeutic Agent Through SYK Inhibition in AML." Frontiers in Pharmacology 17 (2026): 1741351. https://doi.org/10.3389/fphar.2026.1741351.

MLA (9th ed.) Citation

BE, Jeon, et al. "Visomitin as a Differentiation-inducing Therapeutic Agent Through SYK Inhibition in AML." Frontiers in Pharmacology, vol. 17, 2026, p. 1741351, https://doi.org/10.3389/fphar.2026.1741351.